|
  
- 积分
- 635
- 威望
- 635
- 包包
- 192
|
本帖最后由 flydayzhu 于 2010-8-28 16:37 编辑 & f$ ?$ M+ y. x# e7 E- r( y; S
; d! _2 e M0 ]: l
麻烦大家了,最好是能够提供杂志版的,看着相对舒服点,谢谢~
1 p3 W: Y* g9 L
2 R+ ^8 L# c3 H% s1.Promotion of direct reprogramming by transformation-deficient Myc.
' l/ G. d; Y. {9 `2 ~2 p$ | uNakagawa M, Takizawa N, Narita M, Ichisaka T, Yamanaka S.
( R2 F" z7 c0 W t
- ?" O) i# W; B [- I) SCenter for iPS Cell Research and Application, Kyoto University, Kyoto 606-8507, Japan. nakagawa@cira.kyoto-u.ac.jp
: [* k& N9 _$ d' o; khttp://www.ncbi.nlm.nih.gov/pubmed/20660764+ `4 b$ {0 r$ K) N* T1 }
' i4 o2 [6 p+ ]" t0 ]
2.Stem Cells. 2010 Aug;28(8):1349-54.4 b) _7 | c% L3 H- v- }# |7 F( v
Aberrant epigenetic silencing of tumor suppressor genes is reversed by direct reprogramming.5 q0 K2 w# w* N2 O" a# {+ o
Ron-Bigger S, Bar-Nur O, Isaac S, Bocker M, Lyko F, Eden A.4 a s. r+ I4 Y7 l8 ]+ [/ q2 O
6 v5 X0 D# q: @" k
Departments of Cell and Developmental Biology, Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel.) p6 A6 P+ T3 T/ w! a! x( y) O
http://www.ncbi.nlm.nih.gov/pubmed/20572015
& e. }, o% {2 h/ f3 s2 a* t7 C
$ ^- H1 E2 R0 m1 ~3.Nat Biotechnol. 2010 May;28(5):521-6. Epub 2010 May 2.
+ ^* e& ^' Y9 Z" a1 g5 [$ ]Dynamic single-cell imaging of direct reprogramming reveals an early specifying event.1 k. `) G- O0 c5 Q2 N$ @
Smith ZD, Nachman I, Regev A, Meissner A.( v7 h& K2 U; Z) E8 @2 O
! W; V2 g1 q6 A* ?: f8 X* [
Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
) Y5 q" B& Z% r3 H, v5 XComment in:
5 H* n$ z; m) m0 p* Y' G" L2 N$ d: E7 M
Regen Med. 2010 Jul;5(4):501-3.* i9 c9 O+ T! j4 U# C2 d
http://www.ncbi.nlm.nih.gov/pubmed/20436460
; ]: h1 Z- ~2 n. V+ G1 h& y. U3 b2 F- k8 e/ T0 |' | u
4.PLoS One. 2010 Mar 24;5(3):e9838.3 c/ g4 O& V& J7 i
Direct reprogramming of rat neural precursor cells and fibroblasts into pluripotent stem cells.
/ g& p- u. r2 t- [Chang MY, Kim D, Kim CH, Kang HC, Yang E, Moon JI, Ko S, Park J, Park KS, Lee KA, Hwang DY, Chung Y, Lanza R, Kim KS.1 D/ C. J+ X# |+ p( B; [; m
* f- ?0 E; \' }
Molecular Neurobiology Laboratory, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, United States of America./ ^8 @% X- S- H+ Q# G
http://www.ncbi.nlm.nih.gov/pubmed/20352099
, i2 n0 @ A+ p+ {$ U0 V }
9 h1 H; r' x. n' x5.Dev Growth Differ. 2010 Apr;52(3):319-33. Epub 2010 Mar 7.2 z3 p% C6 g1 m" m" }
Direct reprogramming 101.) R! w2 c/ p& T9 Y$ \8 v
Takahashi K.. x1 a9 q- V' K8 k s1 L ^9 F
; h0 L2 z2 J; {& F4 mCenter for iPS cell Research and Application, Institute for Integrated Cell-Material Sciences, Kyoto University, Sakyo-ku, Kyoto, Japan. takahash@cira.kyoto-u.ac.jp) n/ N5 k, f5 t3 d; H+ e% G
http://www.ncbi.nlm.nih.gov/pubmed/20298260+ i7 t+ x C( W7 Z/ R5 z
) w) g4 H; p* m, X2 s/ n
6.Nature. 2009 Oct 1;461(7264):649-3.
. n" u* `9 O+ A8 l. |& PDirect reprogramming of human neural stem cells by OCT4.
: V0 B- Q8 E7 F) _ p! V! @Kim JB, Greber B, Araúzo-Bravo MJ, Meyer J, Park KI, Zaehres H, Schöler HR.
) o/ q+ L9 A, H; G* U) j
$ A4 d2 k: E2 ~. RMax Planck Institute for Molecular Biomedicine, Department of Cell and Developmental Biology, Röntgenstrasse 20, 48149 Münster, NRW, Germany., l. [% ~/ N, {$ {
http://www.ncbi.nlm.nih.gov/pubmed/19718018
5 N0 z( D2 v5 |" ?9 L3 `8 @! \. Q
7.Blood. 2009 Aug 27;114(9):1764-7. Epub 2009 Jun 29.4 C- P2 ?' |+ q/ R3 w
Definitive proof for direct reprogramming of hematopoietic cells to pluripotency.
7 i7 b/ G+ n6 c, AOkabe M, Otsu M, Ahn DH, Kobayashi T, Morita Y, Wakiyama Y, Onodera M, Eto K, Ema H, Nakauchi H.
6 Z% n: d: D4 f: E$ [6 L' t1 \1 X; S7 Y# w
Division of Stem Cell Therapy, Center for Stem Cell and Regenerative Medicine, Institute of Medical Science, University of Tokyo, Tokyo, Japan.
0 A/ l/ R- { B. S6 B, T# {http://www.ncbi.nlm.nih.gov/pubmed/19564635
0 l! W n; x* O% B
! S$ O: X y6 h) Y* b8.Cell Biol Int. 2009 Dec;33(12):1268-73. Epub 2009 Jun 12.
! Y n1 {+ }) CRole of MEF feeder cells in direct reprogramming of mousetail-tip fibroblasts.
4 Y- G( j+ m/ L) nChen M, Sun X, Jiang R, Shen W, Zhong X, Liu B, Qi Y, Huang B, Xiang AP, Ge J.2 G9 _9 a0 L& d2 w# s! K
' I. ^' ^ u! y6 v& {# f7 v/ `. H
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou 510060, China.
+ v9 Z. ^7 P3 k. E, N' Fhttp://www.ncbi.nlm.nih.gov/pubmed/19524692
1 X9 w' ^% u8 z! p% ?% C- Z' T% ~: L/ U4 k1 C" e/ F$ p
9.Mol Ther. 2009 Jun;17(6):947-53. Epub 2009 Mar 31.
1 B% [" H6 ]) O9 a. V9 I2 |Upping the ante: recent advances in direct reprogramming.& g9 V; S B0 _) l
Müller LU, Daley GQ, Williams DA.4 k1 G- J, A- O' X" r
* c- z- X8 g( B8 i% ~3 c& t4 @6 L1 h. Z
Department of Medicine, Division of Pediatric Hematology Oncology, Children's Hospital Boston, Boston, Massachusetts 02115, USA.8 Y* X$ T3 r% ]
Comment in:3 W2 G7 D6 n1 |# d% r( t" h9 F
! D4 T& F; \, d3 B0 mMol Ther. 2009 Jun;17(6):929-30.* X \8 L- _) ?
http://www.ncbi.nlm.nih.gov/pubmed/19337233
' A! c5 S4 `5 K' Y5 ~ B2 c" }8 ^$ ~% [' s" w S, u4 v( D- Q$ m9 ?
10.Cell Stem Cell. 2008 Sep 11;3(3):346-53.7 Y: K0 ?1 `' X6 }5 Z5 @! |
A drug-inducible system for direct reprogramming of human somatic cells to pluripotency.
0 q' M9 t. b) c- g# G% pHockemeyer D, Soldner F, Cook EG, Gao Q, Mitalipova M, Jaenisch R.
+ |% \8 M5 t. W: O- l9 i2 A0 }
9 Y! K5 R8 q. A6 f9 [9 qThe Whitehead Institute, 9 Cambridge Center, Cambridge, MA 02142, USA.
; s5 c( l- s( m7 ?http://www.ncbi.nlm.nih.gov/pubmed/18786421
/ q0 M- i3 Z6 R+ ~ K( {6 t% P8 O) M) }3 A
11.Nat Biotechnol. 2008 Aug;26(8):916-24. Epub 2008 Jul 1.% |: Z* V9 v6 K' g( m
A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types.
) ~0 D$ b) T1 `5 E% w$ q( IWernig M, Lengner CJ, Hanna J, Lodato MA, Steine E, Foreman R, Staerk J, Markoulaki S, Jaenisch R.. F: V. J* ~3 L, F9 Z7 [
0 k" B; O4 M/ t% z6 h0 c! d
Whitehead Institute for Biomedical Research, 9 Cambridge Center, Cambridge, Massachusetts 02142, USA.
7 [) x! F1 X O- \ a* Ihttp://www.ncbi.nlm.nih.gov/pubmed/18594521
, N9 q. o- J+ g' l P9 f% n5 H* k+ _. k
12.Nature. 2008 Jul 3;454(7200):49-55. Epub 2008 May 28.- `$ m7 L0 w) h" w' D
Dissecting direct reprogramming through integrative genomic analysis.
8 {( G. b5 t0 M2 W8 X5 {# S U# qMikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A.
" e; M& H7 r9 ^/ F' O9 P$ ~' k7 m2 m' {
Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.% @- a- `5 F4 H6 Y
http://www.ncbi.nlm.nih.gov/pubmed/185093348 b. A8 R0 S) o- u z
% d* L4 r/ K" i& }: X13.Cell. 2008 Apr 18;133(2):250-64.' ^+ P! @2 l. x, H4 g- h
Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
6 M: \! N F* h% DHanna J, Markoulaki S, Schorderet P, Carey BW, Beard C, Wernig M, Creyghton MP, Steine EJ, Cassady JP, Foreman R, Lengner CJ, Dausman JA, Jaenisch R.
% G% J$ A) v0 F) x$ v- Q6 r
: C6 Q; `1 Y! \8 l, H, G2 nThe Whitehead Institute for Biomedical Research, Cambridge, MA 02142, USA.
{ t$ f& I k) Zhttp://www.ncbi.nlm.nih.gov/pubmed/184231972 P7 H1 p: z' b, A6 Z/ C2 R& t
" T: A- Z" J5 l7 d( T14.Cell Stem Cell. 2008 Feb 7;2(2):151-9.5 p( K4 ^" m( |* W
Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.
( N0 r' A) u$ P( I% ~0 m- Z/ w# ZBrambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, Suh H, Jaenisch R.
8 b, R* M6 S6 D- S& P4 r% n( @& F$ z' A! p' {1 p8 a5 M: t8 S; l
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, 9 Cambridge Center, Cambridge, MA 02142, USA.' s! e' b8 M5 j; d
http://www.ncbi.nlm.nih.gov/pubmed/18371436
1 ]; } N! E6 d3 b4 N% I5 [
) G, C1 I. d. U5 s" y {3 q+ N15.Cell Stem Cell. 2008 Jan 10;2(1):10-2. Epub 2007 Dec 13.4 W9 d- W' r/ h0 y! k+ Z
c-Myc is dispensable for direct reprogramming of mouse fibroblasts.
/ |2 N! T9 I2 i7 j7 L/ AWernig M, Meissner A, Cassady JP, Jaenisch R.
9 v' v: \/ x0 x# f0 q, n3 Q* }http://www.ncbi.nlm.nih.gov/pubmed/18371415
9 K& H4 O! M& s) s- e+ `( F" B' ]# @% y( {! `
16.Cell Stem Cell. 2007 Dec 13;1(6):593-4.
, |1 e4 s' s7 O) J4 _0 ~/ QThe first direct reprogramming of adult human fibroblasts.
. u2 a0 r3 b$ W& U4 u" D$ e) ^2 \Wilmut I.
* B4 _- ?+ S7 d1 H" J0 X4 l
: c- \+ `) Z# ]% F9 @8 r" eScottish Centre for Regenerative Medicine, University of Edinburgh, Edinburgh EH16 4SB, UK. ian.wilmut@ed.ac.uk
8 ?6 d& k0 k) }- l# hhttp://www.ncbi.nlm.nih.gov/pubmed/183713964 A0 j% W& E$ \4 B$ F, I
1 G% n7 T# ^0 h0 Y2 Z, I4 m17.Nat Biotechnol. 2007 Oct;25(10):1177-81. Epub 2007 Aug 27.
. f2 z" z) T+ Q$ M* P4 Z4 p: @Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
: H0 j' O5 s4 O3 G/ OMeissner A, Wernig M, Jaenisch R.
6 m! E' z( K3 D% V8 o9 i. A; r% g, n! u$ l p6 f; s
Whitehead Institute for Biomedical Research, Massachusetts Institute of Technology, Nine Cambridge Center, Cambridge Massachusetts 02142, USA.
1 b: \1 |9 N4 b5 jhttp://www.ncbi.nlm.nih.gov/pubmed/17724450 |
|